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Increased Procollagen mRNA Levels in Scleroderma Skin Fibroblasts 
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Pro collagen messenger RNA activity in scleroderma 
and normal skin fibroblasts was measured using a cell-
free translation assay. Radioactive translation products 
were fractionated by electrophoresis and the ratio of 
pro collagen to total incorporation was determined from 
densitometric scans of gel fluorograms. In 4 scleroderma 
cell lines 1.78% (± 0.10) of incorporated [,r,S]-methionine 
was in procollagen, compared to 1.00% (± 0.20) in 5 
normal controls. These values are consistent with pre-
viously reported increases in the rates of collagen syn-
thesis obtained with intact cells and show that most if 
not all of the increase can be explained on the basis of 
elevated translatable procollagen messenger RNA in 
scleroderma fibroblasts. 
Several stuilies have shown that the excessive accumulation 
of collagen in scleroderma skin is associated with .an increased 
rate in collagen synthesis. Incorporation of railioactive proline 
into h ydxoxyproline and bacterial collagenase-sensitive poly-
peptide synthesis was greater in cultured scleroderma skin 
fibroblasts when compared to normal controls [1-3]. It was ' 
later shown that not all skin fibroblasts display the same 
biosynthetic potential for collagen synthesis. Thus, fibroblasts 
cultured from the lower levels of the dermis and junction 
between the dermis and subcutaneous tissue make more colla-
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gen than those derived from the upper dermis or subcutaneous 
tissue [2,4,5]. Collagenase activity of scleroderma fibroblasts 
was found to be normal [3]. In addition, the ratio of type I/type 
III collagen was the same as the normal controls [3,5]. It is also 
noteworthy that higher incorporation rates of labeled proline 
in scleroderma cell lines could not be attributed to differences 
in the proline pool [3]. The purpose of this study was to measure 
pro collagen RNA activity from scleroderma and normal skin 
fibroblasts by translation in an mRNA-dependent reticulocyte 
lysate. OUf results showed that scleroderma fibroblasts con-
tained more pro collagen mRNA activity than normal controls. 
MATERIALS AND METHODS 
Shin Biopsies and Cell Cultures 
Excision biopsies were performed under local xylocaine anesthesia 
from the upper 31'ms or forearms of 4 patients with active systemic 
scleroderma and 5 normal controls after obtaining consent statements. 
Clinical information about patients is reported in Table I. The normal 
controls consisted of 3 females and 2 males, ranging in age from 28 to 
56 years. Each specimen was divided into smaller pieces and fibroblasts 
derived from the explants were allowed to reach ne31' conl1uency in 60 
x 15 mm plastic culture dishes (Falcon) [4]. Further passages were 
done in 100-mm dishes following trypsinization. 
RNA Preparation 
The procedw·e followed was similar to that described by Bumett and 
Rosenbloom [6]. All solutions and glassware were autoclaved to mini-
mize ribonuclease activity. Cells from 10-20 confluent 100-mm cultme 
dishes were washed twice with I-Ianks' balanced salt solution or 0.02 M 
phosphate-buffered saline, pH 7.5. Then, 2 ml of lysis buffer containing 
1.0% sodium dodecyl sulfate (SDS), 5 mM EDTA, 10 mM Tris-HCI, pH 
7.5, and 65 fLg/ml of proteinase K ·(Beckman) was added to each dish 
and the suspension was scraped into a Dounce homogenizer and ho-
mogenized with 4-5 strokes of a tight-fitting pestle. Following incuba-
tion for 1 h at 45°C, an equal volume of 1 M NaCI was added slowly 
with stirring, and precipitated proteins were removed by centrifugation 
(10 min at 13,000 x g, 25°C). 
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TA BLE I. Clinical data 
C3se no. Age Sex Race Duration Skin Raynaud's Lungs" G.!." Kidneys' phenomenon tract 
1 47 M C 3 Years + + + 
2 31 F B 1 Year + + + + 
3 24 F C 9 Months + + + 
4 31 F C 1 Year + + 
" Lung involvement was assessed by the presence of dyspnea, chest x-ray, and pulmonary function studies. 
/, G.!. involvement was assessed by clinical symptoms and upper gastroin testinal radiologic examinations. 
,. Rena l status was eva luated by measw'ing blood pressure and assaying for prote inuJ'ia, blood m ea ni trogen, and creatinine. 
Oligo-dT cellulose grade T -2 (Collaborative Resear ch) was added to 
the supernate (50 mg/ lO dishes) and the suspension was stuTed gently 
for 30 min at 25°C. A brief centrifugation at room temperature (1 min 
at 500 X g ) was used to pellet the cellulose, which was then washed in 
the fo llowing series of solut ions: Solu tion 1 (0.5 M NaCl, 0.5% SDS, 4 
mM EDTA, 10 mM Tris-HCI, pH 7.5); Solu t ion 2 (0.5 M NaCI, 4 mM 
EDTA, 10 mM Tris-HCI, pH 7.5); and Solu tion 3 (0.5 M NaC!) . T he 
cellulose was washed 3 t imes wi th each solu t ion (75 ml/50 mg fo r each 
wash) . The washed pellet was then suspended ul 1 ml of Solut ion 3 and 
transferred into a I-ml disposable pippeter t ip. When the solu t ion had 
dmined through the t ip, leaving the cellulose behind, sterile HiD was 
carefully added to elu te bound mRNA, and 12 2-dJ'Op fractions (50 III 
each) were collected in autoclaved 1.5-mJ polypropylene tubes (Epen-
dorf). An a liquot of each was used to determine the absorbance at 260 
nm (A2,;o), and tubes conta ining the absorbance peak of elu ted mRNA 
(usua lly 5-10 Ilg/ lO dishes) were stored at '- 80°C un t il used for trans-
lation. 
Assay of Cell-Free Pro collagen Synthesis 
The condi tions used to translate proc'oLlagen mR NA and to analyze 
the ce ll -free t ranslation products were essentia lly the same as described 
by Graves et aI [7]. R NA samples were translated in a R NA-dependent 
rabbi t reticulocyte lysate (Amersham Corp.) containing ["'S)-methio-
nine. Reaction mixtures of 12 III conta ined 10 III of lysate, 1 111 of ["r,S]_ 
methionine (1200 Ci/mM, Amersham Corp.) , and 1 III of mRNA pre-
pared as described. After incubation for 2 h at 22°C, an aliquot (2 Ill ) of 
each reaction mixtw'e was assayed fo r trichloroacetic acid-precipitable 
incorporation as described by Pelham and J ackson [8], and the remain-
der was analyzed by electrophoresis on a 6% polyacrylamide/ SDS slab 
gel [7]. Fluorograms made from the dried gel [9] were scanned at 550 
nm in a Beckman D U-8 spectrophotometer. 
To quantitate cell-free proco Llagen synthesis, two densitometric trac-
ings were made of each electrophoretic separation. The fu'st was made 
at a reduced sensitivity so as to accomodate all of the radioactive 
material on the same scan, and was used to measure total incorporation. 
T he second was made at a 4-fold greater sensit ivi ty to include only the 
procoUagen peaks. The relative amount of pro collagen synthesis was 
expressed as the ratio of procollagen to total incorporation. 
R ESULTS 
When cul t ured huma n skin fibroblast R NAs wer e translated 
in a mRNA-de pe ndent r a bbi t reticulocyte lysate, 3 products 
migrating in th e region of chick pl'Oal (I) a nd proa2 s ta ndard 
were d etected by electrophOJ'esis (Fig 1) . The upper ba nd 
migrated som ewhat faster t ha n chick pr oal (I ), was suscep tible 
to bacteria l collagenase digestion (not sh own), and was desig-
nated pl'Oa l (I) . T h e middle band was not digested by bacterial 
collagen ase, a nd is t h er efor e n ot collagenous . The lower ba nd 
comigrated wi th chick proa2, was digested by bacterial colla-
genase, a nd was designa ted procr2. 
Incorporation of C"S]-methionine into protd (I) a nd proa2 
polyp ep t ides in t he cell-fr ee system was used to estimate t h e 
relative activit ies o f t h e corresp onding m R N As in sclerod erma 
a nd control fibroblasts. T a ble II shows H.e data obtained from 
7 sclerod erm a a nd 14 normal control RNA preparations. P ro-
collagen mRNA activi ty (as a fraction of th e total activity ) was 
high er in th e 4 scl er oderma lines examined, 1. 78% (ra nge, 1.17-
2.67), as compaTed to t h e contr o ls, 1.07% (ra nge, 0.55-1.48). W e 
conclude that an excessive am ount of translatable procollagen 
mR NA con tribu tes to t h e overpToduction of collage.n in skin 
sclerodeTma fibrobl asts. 
2 3 4 5 & 1 a 9 10 11 12 13 14 15 
FIG 1. Fluorograph of [ar'S]-methionine labeled translation products 
synthesized in reticulocyte lysate. Cell-free translations conta ined no 
added mRNA (lanes 1 and 2), chick calvaria mRNA (lane 3), and 
mRNA from several cultured skin fibroblast contro l and scleroderma 
lines (lanes 4-14). A type I procollagen standard (lane 15), was pur ified 
from the meruum of freshly isolated chick tendon ceUs as described 
[7]. The dots between lan.es 8 and 9 indicate 3 fibrob last mRNA 
translation products migrating in the region of the chick procollagen 
standards. Of these, only the uppermost and lowermost were digestable 
with bacterial collagenase and are referred to as proal and proir2, 
respectively. 
T ABLE II. mRNA levels in scleroderm.a fibroblasts 
Scleroderma Normals 
Case # 1 1.72" (3)" Case #1 1.19 (5) 
Case #2 1.70 (1) Case #2 0.92 (2) 
Case #3 1.92 (2) Case #3 1.20 (1) 
Case #4 1.79 (1) Case #4 0.94 (3) 
Case #5 0.74 (3) 
Mean ± SD 1.78 ± 0.10 Mean ± SD 1.00 ± 0.20 
"Cell-free incorporation of [,"'Sl-methion ine in procollagen as % of 
total incorporation. 
" Number of determinations. 
DISCUSSION 
In t his study, a cell-free translation assay was used to deter-
mine th e r elative levels of functional mRN A in several n ormal 
control a nd scleroderma cul t ured skin fibroblast p opulations. 
T h e o bjective was to determine wheth er t h e enhan ced rates of 
collagen biosynth esis in active systemic scleroder ma, demon -
strated in several earlier studies, could be correlated with a 
similar enha ncem ent in t he level of functional procollagen 
mRN A. This approach h as been taken in several recent stu d ies 
to assess th e collagen m R N A conten t in a variety of experin1en-
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tal models where changes were known to occur in the rates of 
collagen synthesis. D uring embryonic and fetal development, 
the rates of collagen synthesis measured in explants from sev-
eral chick and sheep tissues closely paralleled the levels of 
pro collagen mRNA per cell as measured either by cell-free 
translation or by hydridization with complementary DNA. This 
was true of chick calvaria [10] and of sheep lung and tendon 
[11], but not of sheep skin, where type I procollagen mRNA 
remained at high levels during early development despite t he 
sharp decline of type I collagen synthesis. These observations 
suggested a transcriptional-level control of collagen synthesis 
in calvaria, lung, and tendon; however, different mechanisms 
may be operative in the skin. In another study, conflu ent 
cul tures of human fetal lung fibroblasts were shown to contain 
twice the number of procollagen mRNA molecules as compared 
to similar studies performed in cultures at the logarithmic 
growth phase [12]. 
The dramatic decrease in type I pro collagen synthesis dming 
the transformation of chick embryo fibroblasts by Rous sar-
coma virus has been investigated in several laboratories [13]. 
T his decrease was accompanied by a similar reduction in trans-
latable pro collagen mRNA [14] which was subsequently con-
fumed by hydridization of collagen mRNA to complementary 
DNA probes [15-17]. These results indicate that collagen 
mRNA levels are likely to be t he major determinants of collagen 
synthesis dill'ing transformation. An example of hormonal me-
diation of collagen synthesis at the transcription level was 
observed in cultured fetal rat calvaria where, in the presence of 
parathyroid hormone, there was a 50% reduction in collagen 
synthesis and a 40% drop in the level of functional procollagen 
mRNA [18]. Likewise, the shift from type II to type I collagen 
production induced in chick embryo chondrocyte cultures by 5-
bromo-2-deoxyuridine was paralleled by an increase in trans-
latable mRNA for type I collagen [19]. 
T he above results indicate that in most instances, changes in 
collagen synthetic rates correlate with th e level of transcription. 
However, it is still not known which mechanism(s) is used by 
collagen-producing cells to regulate th e levels of pro collagen 
mRNA. T he application of cloned procollagen-specific cDNA 
probes and genomic DNA sequences to questions regarding the 
number of procollagen genes, their transcription rates, the 
processing and transport of the mRN A precursors, and the half-
life of procollagen mRNA in the cytoplasm should further 
elucidate the basic control mechanism. 
Our results with scleroderma fibroblasts provide evidence 
that previously reported increases in collagen biosynthesis can 
be accounted for, at least in part, by an increased content of 
translatable procollagen mRNA. Our studies did not distinguish 
the mRNAs for types I and III pro collagens, the predominant 
species in the skin. However, it has previously been shown that 
the ratio of type I/ III synthesis is unchanged in scleroderma 
fibroblasts and thus it is likely that the mRNAs for both types 
increase proportionately. As with other situations described 
above, determination of th e precise mech anism accounting for 
the increase of pro collagen rnRNA in scleroderma fibroblasts 
should soon be feasible with the recent isolation of collagen-
specific cDNA probes. 
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Announcement 
A course entitled "Injectable Collagen: Investigation, Applications, Techniques," sponsored by t he Department 
of Dermatology, Washington Hospital Center, Washington, D. C. will be given April 29-30, 1983. For further 
information: Thomas p , Nigra, M.D., Chairman, Department of Dermatology, W.H.C., 110 Irving Street N.W. #2B-
44, Washington, D . C. 20010 (202/541-6227. 
